NCT03599999View on ClinicalTrials.gov

Study of Adverse Effects Occuring in Patients Receiving an Antibiotic Treatment With Temocillin

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

March 24, 2017

Primary Completion Date

December 29, 2017

Study Completion Date

December 29, 2017

Conditions
Bacterial Infection With One or More Extended Spectrum Betalactamases Remaining Susceptible to Temocillin
Interventions
DRUG

Adverse events detection

type of adverse events detected during treatment with Temocillin and imputed to Temocillin

Trial Locations (1)

80054

CHU Amiens-Picardie, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT03599999 - Study of Adverse Effects Occuring in Patients Receiving an Antibiotic Treatment With Temocillin | Biotech Hunter | Biotech Hunter